| Name | Title | Contact Details |
|---|---|---|
David Everett |
Chief Information Officer | Profile |
T3D Therapeutics` mission is to develop its lead drug product candidate, T3D-959, as a potential `First-in-Class`and `Best-in-Class` disease-modifying, breakthrough medicine for the treatment of Alzheimer`s disease with the potential to slow, stop or reverse the course of the disease. The Company is also seeking to maximize the therapeutic utility of T3D=959 and has initiated pre-clinical studies in Huntington’s Disease models.
SaluGenecists Inc is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
eScribe provides industry-leading scribe staffing for hospitals and physician-owned groups across the nation in a variety of emergency medicine and outpatient settings. eScribe has a proven track record in creating programs that are financially viable and produce a sustainable, positive return on investment for its partners.
Heartland Dental Care is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Thames Valley Children's Centre is a London, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.